These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25618267)

  • 1. Liver injury may increase the risk of diazoxide toxicity: a case report.
    Tas E; Mahmood B; Garibaldi L; Sperling M
    Eur J Pediatr; 2015 Mar; 174(3):403-6. PubMed ID: 25618267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of diazoxide treatment in persistent neonatal hyperinsulinism.
    Abu-Osba YK; Manasra KB; Mathew PM
    Arch Dis Child; 1989 Oct; 64(10):1496-500. PubMed ID: 2684032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of severe diazoxide toxicity.
    Silvani P; Camporesi A; Mandelli A; Wolfler A; Salvo I
    Paediatr Anaesth; 2004 Jul; 14(7):607-9. PubMed ID: 15200661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
    Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
    Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI).
    Raisingani M; Brar PC
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1241-1245. PubMed ID: 31465295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report.
    Darendeliler F; Bundak R; Bas F; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 1997; 10(1):79-81. PubMed ID: 9364348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinism in infants and children: diagnosis and therapy.
    Stanley CA; Baker L
    Adv Pediatr; 1976; 23():315-55. PubMed ID: 795282
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria.
    Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM
    Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinaemic hypoglycaemia in infancy and childhood: a practical approach to diagnosis and medical treatment based on experience of 18 cases.
    Soltész G; Jenkins PA; Aynsley-Green A
    Acta Paediatr Hung; 1984; 25(4):319-32. PubMed ID: 6395878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy.
    Yildizdas D; Erdem S; Küçükosmanoglu O; Yilmaz M; Yüksel B
    Adv Ther; 2008 May; 25(5):515-9. PubMed ID: 18512033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia.
    Clark W; O'Donovan D
    Am J Perinatol; 2001 Jun; 18(4):175-8. PubMed ID: 11444360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of pulmonary hypertension in an infant treated with diazoxide.
    Nebesio TD; Hoover WC; Caldwell RL; Nitu ME; Eugster EA
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):939-44. PubMed ID: 17937066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazoxide for Severe or Recurrent Neonatal Hypoglycemia: A Randomized Clinical Trial.
    Laing D; Walsh EPG; Alsweiler JM; Hanning SM; Meyer MP; Ardern J; Cutfield WS; Rogers J; Gamble GD; Chase JG; Harding JE; McKinlay CJD
    JAMA Netw Open; 2024 Jun; 7(6):e2415764. PubMed ID: 38869900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
    Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A
    Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide.
    Demirel F; Unal S; Çetin II; Esen I; Arasli A
    J Pediatr Endocrinol Metab; 2011; 24(7-8):603-5. PubMed ID: 21932611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leucine sensitive hypoglycemia. Follow-up studies under treatment with diazoxide (author's transl)].
    Lücking T
    Eur J Pediatr; 1976 Mar; 121(4):287-300. PubMed ID: 1278187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe transient neonatal hyperinsulinism associated with hyperlactataemia in non-asphyxiated infants.
    Hussain K; Thornton PS; Otonkoski T; Aynsley-Green A
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):203-9. PubMed ID: 15055355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal hyperinsulinemic hypoglycemia. Two case reports.
    Zaffanello M; Zamboni G; Maffeis C; Antoniazzi F; Tatò L
    Minerva Pediatr; 2002 Aug; 54(4):325-33. PubMed ID: 12131869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed presentation of prolonged hyperinsulinaemic hypoglycaemia in a preterm small-for-gestational age neonate.
    Chong JH; Chandran S; Agarwal P; Rajadurai VS
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24351577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.